Pillstats
Rx only · For Solution · Ophthalmic

Cetirizine

Brands: Zerviate · Cetirizine

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)20610
US makers1 labelers
Packages1
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$2.12$4.23$6.35$8.46Nov 2025May 2026Jul 2026
$7.357
Latest avg · Jul 22, 2026
+0%
Since Nov 5, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

671332002672025 Q32025 Q42026 Q1
232
Rx · 2026 Q1
1.7K
Units dispensed
3
Quarters · since 2025 Q3

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Harrow Eye, LLCunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.